We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+9.45%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$428B
AUM Growth
-$10.7B
Cap. Flow
-$22.3B
Cap. Flow %
-5.22%
Top 10 Hldgs %
27.96%
Holding
16,128
New
3,614
Increased
5,201
Reduced
5,802
Closed
1,312

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$913M
2
META icon
Meta Platforms (Facebook)
META
+$659M
3
CAT icon
Caterpillar
CAT
+$450M
4
PYPL icon
PayPal
PYPL
+$435M
5
BDX icon
Becton Dickinson
BDX
+$348M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$860M
2
HUM icon
Humana
HUM
+$581M
3
GS icon
Goldman Sachs
GS
+$372M
4
BSX icon
Boston Scientific
BSX
+$345M
5
WMT icon
Walmart Inc
WMT
+$327M

Sector Composition

Rank Sector Weight
1 Technology 3.36%
2 Healthcare 2.87%
3 Financials 2.57%
4 Consumer Discretionary 2.23%
5 Industrials 2.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIA icon
14101
CALL
Citizens
CIA
$201M
$3.62K ﹤0.01%
+1,700
New +$4.74K
XOS icon
14102
Xos
XOS
$28.8M
$3.62K ﹤0.01%
272
-2,445
-90% -$63K
SBSI icon
14103
CALL
Southside Bancshares
SBSI
$986M
$3.6K ﹤0.01%
+100
New +$3.55K
STVN icon
14104
PUT
Stevanato
STVN
$5.75B
$3.59K ﹤0.01%
+200
New +$3.32K
ESM.WS
14105
DELISTED
ESM Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ESM.WS
$3.59K ﹤0.01%
30,835
-214,031
-87% -$27.7K
ARBK
14106
PUT
Argo Blockchain
ARBK
$42.1M
$3.56K ﹤0.01%
15
-70
-82% -$19.4K
RJAC.WS
14107
DELISTED
Jackson Acquisition Company Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
RJAC.WS
$3.56K ﹤0.01%
624,369
DRTSW icon
14108
Alpha Tau Medical Warrant
DRTSW
$87.6M
$3.56K ﹤0.01%
14,226
-40,243
-74% -$12.3K
ARAY icon
14109
PUT
Accuray
ARAY
$33.2M
$3.55K ﹤0.01%
+1,700
New +$3.51K
SJI
14110
CALL
DELISTED
South Jersey Industries, Inc.
SJI
$3.55K ﹤0.01%
+100
New +$3.46K
URGN icon
14111
PUT
UroGen Pharma
URGN
$2.35B
$3.55K ﹤0.01%
+400
New +$3.79K
PINS icon
14112
Pinterest
PINS
$13.6B
$3.54K ﹤0.01%
146
-3,878,729
-100% -$92.5M
ECVT icon
14113
CALL
Ecovyst
ECVT
$1.14B
$3.54K ﹤0.01%
+400
New +$3.69K
ECVT icon
14114
PUT
Ecovyst
ECVT
$1.14B
$3.54K ﹤0.01%
+400
New +$3.69K
BKYI
14115
BIO-key International
BKYI
$3.46M
$3.52K ﹤0.01%
+33
New +$7.18K
CRDF icon
14116
CALL
Cardiff Oncology
CRDF
$74.9M
$3.5K ﹤0.01%
2,500
-53,300
-96% -$76.3K
RKDA icon
14117
CALL
Arcadia Biosciences
RKDA
$1.36M
$3.5K ﹤0.01%
323
-2
-0.6% -$28
PRA
14118
PUT
DELISTED
ProAssurance
PRA
$3.49K ﹤0.01%
+200
New +$3.94K
HOWL icon
14119
CALL
Werewolf Therapeutics
HOWL
$19.7M
$3.48K ﹤0.01%
+1,700
New +$4.45K
DBTX
14120
PUT
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$3.48K ﹤0.01%
1,700
-33,000
-95% -$101K
ARKO icon
14121
CALL
ARKO Corp
ARKO
$544M
$3.46K ﹤0.01%
400
-15,100
-97% -$140K
REVBU
14122
DELISTED
Revelation Biosciences, Inc. Unit
REVBU
$3.46K ﹤0.01%
+17,315
New +$5.33K
USHY icon
14123
PUT
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.2B
$3.45K ﹤0.01%
100
-19,800
-99% -$684K
CLNN icon
14124
Clene
CLNN
$52.9M
$3.45K ﹤0.01%
173
-1,650
-91% -$38.3K
OIG
14125
PUT
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$3.45K ﹤0.01%
438
-117
-21% -$1.34K

Similar funds

Ken Griffin's Q4 2022 Portfolio in Review

As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.

  • Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
  • Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
  • Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
  • Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
  • Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
  • Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
  • Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.